Peripheral Nerve Stimulation for CRPS and Diabetic Neuropathy

Burning, electric, or severe pain in the foot, ankle, or leg can continue long after a motor vehicle accident, workplace injury, fall, fracture, or surgery. Diabetes can also damage the nerves in the feet and lower legs, causing painful diabetic peripheral neuropathy. When nerve pain remains difficult to control, a focused evaluation may identify whether peripheral nerve stimulation (PNS) belongs in the treatment plan.

Family Foot & Leg Center, PA (FFLC) evaluates selected lower-extremity nerve-pain conditions and can discuss FDA-cleared peripheral nerve stimulation systems when the diagnosis, nerve target, medical history, and device labeling fit. The goal is to improve useful function and reduce reliance on narcotic pain medicine when possible. PNS is not a guaranteed cure, and any medication reduction must be directed by the clinician who prescribes it.

Conditions FFLC May Evaluate for Peripheral Nerve Stimulation

Accident-related complex regional pain syndrome

Complex regional pain syndrome (CRPS) usually affects an arm or leg after an injury or procedure. The pain may be much more intense or persistent than expected for the original injury. Lower-extremity symptoms can include burning pain, extreme sensitivity to socks or light touch, swelling, changes in skin color or temperature, sweating changes, stiffness, and difficulty bearing weight.

A motor vehicle collision, workplace injury, fall, crush injury, fracture, immobilization, or foot and ankle surgery can precede CRPS. CRPS is diagnosed clinically; there is no single blood test that confirms it. Because infection, a blood-flow problem, an unhealed fracture, nerve compression, and diabetic foot complications can look similar, a specialist examination matters before a device is considered.

Painful diabetic peripheral neuropathy

Painful diabetic peripheral neuropathy is one of the conditions that may be evaluated for peripheral nerve stimulation. Diabetes-related nerve injury often starts in the toes and feet and may produce burning, pins-and-needles, numbness, stabbing pain, electric shocks, or pain that is worse at night. Numbness also increases the risk of unnoticed blisters, pressure injuries, ulcers, and infection.

Some FDA-cleared percutaneous electrical nerve stimulation systems include an indication for symptomatic relief of chronic, intractable pain from diabetic peripheral neuropathy. That does not mean every stimulator treats every type of diabetic pain. The clinician must confirm the diagnosis, check the skin and circulation, review diabetes control and wound history, and match the selected system to its current labeling.

Post-traumatic focal nerve pain

An accident or operation can irritate or injure a named peripheral nerve in the foot, ankle, or leg. The pain may follow a narrower path than CRPS and can feel burning, shooting, numb, or hypersensitive around a scar or injury. Mapping the painful territory helps determine whether a specific nerve is a reasonable target for PNS.

Selected post-surgical or other peripheral nerve-origin pain

Some patients develop persistent neuropathic pain after foot and ankle surgery, fracture repair, wound treatment, or another procedure. PNS may be discussed as part of a broader plan after the underlying structural, vascular, infectious, and wound-related problems have been assessed. It is not a substitute for repairing an unstable fracture, treating an infection, managing diabetes, or relieving an untreated nerve compression.

What FDA Clearance Means

Patients often ask about an FDA-approved peripheral nerve stimulator. The more precise term for many PNS systems is FDA-cleared through the 510(k) pathway. Clearance is tied to a specific device and its labeled indications; it is not a blanket approval for every pain condition or every patient.

For example, the FDA-cleared SPRINT Peripheral Nerve Stimulation System is labeled for up to 60 days in the back and/or extremities for specified chronic, post-traumatic, post-surgical, and post-operative pain indications. The FDA-cleared First Relief system is labeled for multiple treatments up to 56 days for symptomatic relief of chronic, intractable pain from diabetic peripheral neuropathy. Device duration, placement, contraindications, warnings, and follow-up requirements vary.

FFLC uses the device label as one part of candidacy review. The diagnosis, painful body region, target nerve, treatment history, and health risks must all fit before a clinician recommends a system.

How Peripheral Nerve Stimulation Works

PNS delivers carefully programmed electrical stimulation near a selected peripheral nerve or nerve region. Depending on the system, a thin lead may be placed through the skin for a temporary treatment course, or a trial may be used before considering a longer-term system. The purpose is to modulate pain signaling and create an opportunity for improved activity and rehabilitation.

Before treatment, the care team should define a measurable goal. Examples include walking farther, tolerating a work shoe, sleeping through more of the night, returning to golf or pickleball, completing physical therapy, or using less rescue medication. Pain intensity matters, but function and medication burden help show whether the plan is helping in daily life.

What the Evaluation Includes

1. Confirm the pain pattern

The examination reviews sensation, strength, gait, range of motion, swelling, skin condition, temperature differences, pulses, and pain with light touch. The clinician looks for a pattern consistent with CRPS, diabetic neuropathy, focal nerve injury, structural foot or ankle pain, or more than one condition.

2. Check for urgent or competing causes

Seek prompt medical care for a cold or pale foot, sudden calf swelling, chest pain, shortness of breath, fever, rapidly spreading redness, a new or infected diabetic wound, or rapidly worsening weakness. These symptoms can represent an urgent problem and should not wait for a routine PNS consultation.

3. Identify the target and review prior care

Bring accident or workers' compensation records, imaging, operative reports, therapy notes, injection history, wound records, and a complete medication list. Include the narcotic name, dose, schedule, duration, benefit, side effects, and prescribing clinician. A symptom map and timeline from injury to the current pain can make the evaluation more useful.

4. Build a coordinated plan

PNS may be combined with physical therapy, desensitization, appropriate footwear, wound prevention, diabetes management, nutritional support, and treatment of a structural problem. For a broader discussion of noninvasive electrical stimulation, see FFLC's guide to TENS units for foot and nerve pain. A consumer TENS unit and a prescription PNS system are not interchangeable.

PNS and Narcotic Pain Medicine

The realistic objective is opioid-sparing care, not an automatic promise to remove narcotics. If stimulation reduces pain enough to improve sleep, walking, therapy, or work, the patient and prescribing clinician may have an opportunity to reduce medication. The response varies by diagnosis, nerve target, duration of pain, general health, and the rest of the treatment plan.

Do not stop narcotic medication suddenly. Abrupt changes can cause withdrawal and destabilize pain. The prescribing clinician should set the taper pace, monitor symptoms, and coordinate with the specialist treating the foot or leg. FFLC can evaluate the lower-extremity pain problem and discuss PNS candidacy, but it does not replace the prescriber's role in medication management.

What PNS Can and Cannot Do

• It can: target pain associated with a selected peripheral nerve or region; support a plan centered on function; and give selected patients an opioid-sparing option when conservative care has not restored useful activity.
• It cannot: diagnose CRPS without an examination; repair an unstable fracture; cure an infection or diabetic ulcer; replace diabetes care; or guarantee permanent relief or complete narcotic discontinuation.

Frequently Asked Questions

Can a car accident or workplace injury cause CRPS in the foot or leg?

Yes. CRPS can develop after trauma, fracture, surgery, immobilization, or another injury to a limb. Diagnosis requires a clinical examination because several urgent and non-urgent conditions can cause similar symptoms.

Can peripheral nerve stimulation help diabetic neuropathy pain?

Some FDA-cleared electrical nerve stimulation systems include indications for chronic, intractable pain from diabetic peripheral neuropathy. Candidacy depends on the diagnosis, painful body region, medical history, target, and the selected system's labeling.

Will a peripheral nerve stimulator eliminate narcotic medication?

It may help selected patients reduce reliance on narcotic medication, but complete discontinuation is not guaranteed. Any taper must be gradual when appropriate and supervised by the prescribing clinician.

Is every CRPS patient a candidate for PNS?

No. The pain pattern, target nerve, previous treatment, skin and circulation status, infection risk, medical history, and device labeling all matter. A consultation is needed before a treatment decision.

What should I bring to an evaluation?

Bring imaging and medical records, a medication list, accident or workers' compensation information, a symptom timeline, and examples of activities that pain prevents. For diabetic neuropathy, include wound history and information about diabetes treatment.

Schedule a Lower-Extremity Nerve-Pain Evaluation

Family Foot & Leg Center, PA provides specialist foot and ankle care at 9 Southwest Florida locations serving communities from Marco Island to Sarasota. Call 239-430-3668 to arrange an evaluation or use the online appointment request. The practice's 24/7 AI agents can answer calls and help with appointment scheduling.

Medical disclaimer: This article is for education and does not diagnose or treat an individual condition. Peripheral nerve stimulation is prescription care. Treatment decisions, device selection, and medication changes require an in-person evaluation by qualified clinicians.

Sources

• National Institute of Neurological Disorders and Stroke: Complex Regional Pain Syndrome
• National Institute of Neurological Disorders and Stroke: Peripheral Neuropathy
• FDA 510(k) K181422: SPRINT Peripheral Nerve Stimulation System
• FDA 510(k) K212859: First Relief percutaneous electrical nerve stimulator